← Back to Biomarker Core

Biospecimen Access and Research Enablement for Houston Investigators

January 29, 2026

What this project does
Runs a fair, structured process for investigators to request samples/data and supports high-impact multi-omics projects beyond the P30.

Why it matters clinically
This expands discovery work, accelerates translation, and helps build a larger ecosystem of AD research—without reinventing infrastructure each time.

Key activities
-Operate a Biospecimen Review Committee
-Review requests for scientific merit, feasibility, alignment, and sample availability
-Distribute approved samples and linked data under proper agreements
-Provide technical and analytic support for multi-omic projects (genomics, transcriptomics, proteomics, metabolomics; bulk + single-cell)

What will be delivered
-A standardized request/review/distribution pipeline
-Supported investigator-led discovery projects
-Shared datasets deposited per NIH policy

Who this helps
-Houston-area AD investigators
-Trainees and early-career researchers
-The national AD research community